Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.000
-0.040 (-1.96%)
Dec 26, 2025, 11:31 AM EST - Market open
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $137.93 million as of December 26, 2025. Its market cap has increased by 284.95% in one year.
Market Cap
137.93M
Enterprise Value
110.94M
1-Year Change
284.95%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $137.93M, an increase of 548.69%. That is a compound annual growth rate of 43.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 140.69M | 274.50% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | 70.36M | 230.93% |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |